Submitted by Anonymous (not verified) on 8 August 2024 - 13:00
Human medicines European public assessment report (EPAR): Avzivi, bevacizumab, Date of authorisation: 26/07/2024, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Avzivi, bevacizumab, Date of authorisation: 26/07/2024, Status: Authorised